Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 25,020 |
|
|||||
| News | - | ||||||
| Day High | 2.27 | Low High |
|||||
| Day Low | 2.21 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Check Cap Ltd | CHEK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.07 | -3.06% | 2.22 | 17:16:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.27 | 2.21 | 2.27 | 2.22 | 2.29 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 141 | 25,020 | $ 2.25 | $ 56,374 | - | 1.27 - 4.625 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 669 | $ 2.22 | USD |
Check Cap Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 13.28M | 5.85M | - | 0 | -19.11M | -3.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Check Cap News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHEK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.22 | 2.34 | 2.12 | 2.25 | 34,378 | 0.00 | 0.00% |
| 1 Month | 2.24 | 3.45 | 2.12 | 2.72 | 100,751 | -0.02 | -0.89% |
| 3 Months | 2.08 | 3.45 | 1.78 | 2.48 | 272,059 | 0.14 | 6.73% |
| 6 Months | 3.30 | 3.937 | 1.78 | 2.49 | 137,777 | -1.08 | -32.73% |
| 1 Year | 1.45 | 4.625 | 1.27 | 2.64 | 112,150 | 0.77 | 53.10% |
| 3 Years | 31.40 | 38.178 | 1.22 | 17.59 | 713,111 | -29.18 | -92.93% |
| 5 Years | 52.00 | 89.80 | 1.22 | 29.59 | 2,232,893 | -49.78 | -95.73% |
Check Cap Description
| Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. |
